Ruth Dobson1, Vilija G Jokubaitis2, Gavin Giovannoni3. 1. Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University London; Department of Neurology, Royal London Hospital, BartsHealth NHS Trust. Electronic address: Ruth.dobson@qmul.ac.uk. 2. Department of Neuroscience, Central Clinical School, Monash University, Melbourne. 3. Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University London; Department of Neurology, Royal London Hospital, BartsHealth NHS Trust; Blizard Institute, QMUL.
Abstract
BACKGROUND: Women with MS are advised that relapse rates fall during pregnancy and rebound post-partum. This advice originates from 1998; smaller, more recent, studies have not been previously pooled. METHODS: All studies published since 1998 providing raw relapse data were considered for inclusion. Single arm meta-analysis was performed using a restricted maximum likelihood random effects model with inverse variance; secondary subgroup analysis and meta regression were then performed. Annualised relapse rates (ARR), or relapse numbers/rates suitable for conversion into ARR during pregnancy and the post-partum period were included. Secondary subgroup analysis examined year of data collection, DMT exposure, breastfeeding and data source. RESULTS: 7034 pregnancies from 6430 women were included. ARR fell from 0.57 (95%CI 0.45-0.70) pre-pregnancy to 0.36 (0.28-0.44), 0.29 (0.21-0.36) and 0.16 (0.11-0.21) during trimesters 1,2, and 3, with a post-partum rebound (ARR 0.85, 95%CI 0.70-1.00). ARR reduced pre-pregnancy and post-partum over time (p<0.001). Relapse rates were lower in claims databases than elsewhere. CONCLUSIONS: Despite high heterogeneity, we confirm the historic assumption that ARR reduces during pregnancy, and demonstrate an overall reduction in ARR over time. Studies using data originating from claims databases demonstrated a lower relapse rate at all time points, which has not previously been demonstrated.
BACKGROUND:Women with MS are advised that relapse rates fall during pregnancy and rebound post-partum. This advice originates from 1998; smaller, more recent, studies have not been previously pooled. METHODS: All studies published since 1998 providing raw relapse data were considered for inclusion. Single arm meta-analysis was performed using a restricted maximum likelihood random effects model with inverse variance; secondary subgroup analysis and meta regression were then performed. Annualised relapse rates (ARR), or relapse numbers/rates suitable for conversion into ARR during pregnancy and the post-partum period were included. Secondary subgroup analysis examined year of data collection, DMT exposure, breastfeeding and data source. RESULTS: 7034 pregnancies from 6430 women were included. ARR fell from 0.57 (95%CI 0.45-0.70) pre-pregnancy to 0.36 (0.28-0.44), 0.29 (0.21-0.36) and 0.16 (0.11-0.21) during trimesters 1,2, and 3, with a post-partum rebound (ARR 0.85, 95%CI 0.70-1.00). ARR reduced pre-pregnancy and post-partum over time (p<0.001). Relapse rates were lower in claims databases than elsewhere. CONCLUSIONS: Despite high heterogeneity, we confirm the historic assumption that ARR reduces during pregnancy, and demonstrate an overall reduction in ARR over time. Studies using data originating from claims databases demonstrated a lower relapse rate at all time points, which has not previously been demonstrated.
Authors: Rinze Neuteboom; Joost Smolders; Malou Janssen; Liza Rijvers; Steven C Koetzier; Annet F Wierenga-Wolf; Marie-José Melief; Jamie van Langelaar; Tessel F Runia; Christianne J M de Groot; Marvin M van Luijn Journal: Sci Rep Date: 2021-06-09 Impact factor: 4.379
Authors: Fioravante Capone; Angela Albanese; Giorgia Quadri; Vincenzo Di Lazzaro; Emma Falato; Antonio Cortese; Laura De Giglio; Elisabetta Ferraro Journal: Front Neurol Date: 2022-04-15 Impact factor: 4.003